We suggest that the reduced expression and responsiveness to CD3/CD28 stimulation of ErbB4 expression on immune cells in patients with MS may be related to an insufficient immune mediation of remyelination and oligodendrogenesis in MS. This evidence concerns the gene CD28 and myeloid sarcoma.